Conservative treatment for acute coronary syndrome in patients with type 2 diabetes mellitus

Conservative treatment for acute coronary syndrome in patients with type 2 diabetes mellitus

2 diabetes mellitus (T2DM). Dyspnea during physical exertion should be considered an anginal equivalent in patients with T2DM, and suffocation causing admission to ICU ? as a possible sign of myocardial infarction. Proximal and distal coronary lesions combined with diabetic microangiopathy compromis...

Full description

Bibliographic Details
Main Authors:	Sergey Valentinovich Kakorin, Lev Borisovich Kruglyi, Ashot Musaelovich Mkrtumyan
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2013-06-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus acute coronary syndrome myocardial infarction thromobolytic anticoagulant antiplatelet antianginal beta blocker ace hmg-coa reductase inhibitor
Online Access:	https://dia-endojournals.ru/dia/article/viewFile/3755/1931

Similar Items

Clinical and morphological characteristics, management and prognosis for acute coronary syndrome in patients with type 2 diabetes mellitus
by: Sergey Valentinovich Kakorin, et al.
Published: (2013-06-01)

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
by: Aronow Herbert D
Published: (2002-01-01)

Effect of Diallyl Disulphide on Diabetes Induced Dyslipidemia in Male Albino Rats
by: Naveen Kumar Sambu, et al.
Published: (2015-04-01)

Estatinas hipolipêmicas e novas tendências terapêuticas Hypolipemic statins and new therapeutcal trends
by: Vanessa Leiria Campo, et al.
Published: (2007-04-01)

Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
by: Gårevik Nina, et al.
Published: (2012-03-01)

Control of HMG-CoA reductase activity and sterol synthesis in the lactating mammary gland
by: Smith, R. A. W.
Published: (1987)

Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography
by: I P Williamson, et al.
Published: (1981-01-01)

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay
by: M E Ackerman, et al.
Published: (1977-05-01)

7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts
by: Megumi Honda, et al.
Published: (1998-03-01)

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)
by: S. B. Fitilev, et al.
Published: (2017-05-01)

Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
by: Nijole Bernaitis, et al.
Published: (2018-05-01)

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum
by: J L Merchant, et al.
Published: (1977-11-01)

Studies on the HMG-CoA reductase gene expression in the human parasite Schistosoma mansoni
by: Rajkovic, Aleksandar
Published: (1991)

Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis
by: Ian R. Harris, et al.
Published: (1998-02-01)

Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.
by: Heshun Chen, et al.
Published: (1993-12-01)

A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase
by: Paula Mihaljević-Jurič, et al.
Published: (2021-06-01)

Gene expression of sterol regulatory element-binding proteins in hamster small intestine
by: F. Jeffrey Field, et al.
Published: (2001-01-01)

Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
by: Tuuminen R, et al.
Published: (2016-05-01)

Modulating Liver Cholesterol Metabolism by 3-Iodothyronamine
by: Nasrin KAZEMIPOUR, et al.
Published: (2017-07-01)

Pre and post-stroke use of statins improves stroke outcome
by: Majaz Moonis, et al.
Published: (2014-01-01)

Differences of statin activity in 2D and 3D pancreatic cancer cell cultures
by: Paškevičiūtė M, et al.
Published: (2017-11-01)

Utilization of Statins, an HMG-CoA reductase inhibitors, in Ambon District Hospital, Maluku: a retrospective study
by: Abraham Simatupang, et al.
Published: (2018-10-01)

Inhibition of HMG CoA Reductase and Lipid Peroxidation in The Rats Liver by Selected Zingiberaceae
by: Patonah Hasimun, et al.
Published: (2018-11-01)

Potential drug interactions with statins: Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01)

Atherogenic Impact of Homocysteine: Can HMG-CoA Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?
by: Nikolic Tamara, et al.
Published: (2019-06-01)

Meta-Analysis: Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors in Thoracic Transplant Patients
by: Moon, Rebecca
Published: (2006)

Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus
by: Jeffrey M. Rybak, et al.
Published: (2019-04-01)

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)
by: S. В. Fitilev, et al.
Published: (2018-05-01)

Secondary prevention patterns in persons with pre-existing coronary artery disease: Are we getting it right?
by: Hadi, MF, et al.
Published: (2018)

Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham
by: Alejandro Heres, et al.
Published: (2021-07-01)

Bioactive Pigments of Monascus purpureus Attributed to Antioxidant, HMG-CoA Reductase Inhibition and Anti-atherogenic Functions
by: H. P. Mohankumari, et al.
Published: (2021-02-01)

Inhibitory effects of tangeretin and trans-ethyl caffeate on the HMG-CoA reductase activity: Potential agents for reducing cholesterol levels
by: Inten Pangestika, et al.
Published: (2020-08-01)

Evaluation of Antidiabetic potential and Hypolipidemic activity of Coccinia indica (leaves) in Diabetic Albino rats
by: Mamata Pochhi
Published: (2019-07-01)

Statins & risk of Clostridium difficile infection: A meta-analysis
by: Karn Wijarnpreecha, et al.
Published: (2019-01-01)

Inverse Association between Statin Use and Stomach Cancer Incidence in Individuals with Hypercholesterolemia, from the 2002–2015 NHIS-HEALS Data
by: Hyo-Sun You, et al.
Published: (2020-02-01)

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
by: Huanbiao Mo, et al.
Published: (2019-01-01)

An Evaluation of HMG-CoA Reductase Inhibitor Drug-Drug Interactions for Quality in the Literature
by: Green, Nathaniel, et al.
Published: (2012)

Sufficient production of geranylgeraniol is required to maintain endotoxin tolerance in macrophages
by: Jinyong Kim, et al.
Published: (2013-12-01)

Role and classification of cholesterol-lowering functional foods
by: Zhen-Yu Chen, et al.
Published: (2011-04-01)

Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test
by: Dick C. Chan, et al.
Published: (2002-05-01)